Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19f96132e236557ddba0184edc817975 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ebd9ab30c462e47f9abfdff77f16f7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11ff6377a2cc6f7185b7a72302257120 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-7233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2405-06 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-483 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-283 |
filingDate |
2002-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e7028dca6c9e7ba458741870ff1289 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_356cf8bf32477d5044cec702cd294494 |
publicationDate |
2003-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-03014724-A1 |
titleOfInvention |
A novel cancer marker and uses therefor in the diagnosis of cancer |
abstract |
Provided are novel cancer markers for the diagnosis of cancer in humans and non-human mammalian subjects, specifically a cancer marker comprising a negatively-charged molecule with a mass/charge (m/z) ratio of about 991. The cancer marker of the invention may be used to determine the presence of one or more cancerous cells or tumors in a biological sample by assaying the sample for a reduced level of said cancer marker. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006108095-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9315848-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9551712-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9528979-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3165925-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10697969-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8362415-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006108095-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7728287-B2 |
priorityDate |
2001-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |